L Overview on Hemodialysis Industry in China

Overview on Hemodialysis Industry in China

Bharat Book Bureau provides the report, on “Overview on Hemodialysis Industry in China Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis.. https://www.bharatbook.com/healthcare-market-research-reports-521656/research-report-hemodialysis-industry-china.html

19th Dec2015- Mumbai, India: Bharatbook.com announces a report on “Overview on Hemodialysis Industry in China As Chinese economy develops with increasing income per capita and payment ability of hemodialysis patients, the industry will develop rapidly in the future. The costs of hemodialysis consist of instruments, drugs and services with the proportions of 45%, 25% and 30% respectively. Hemodialysis instruments include dialysis machines, dialyzer and dialysis pipelines.

Hemodialysis (also HD) is one of the replace therapy for patients with acute and chronic renal failure. There are globally 2.2 million uremia patients (end stage renal disease, ESRD) receiving dialysis treatment, including over 89% of them receiving hemodialysis. As the cost of hemodialysis is high, most dialysis patients are concentrated in developed regions like Europe and the U.S. The dialysis patients are fewer in developing countries but increases rapidly. In recent years, the growth rate of dialysis patients in China, India and Brazil remains above 15%, much higher than 3%-5% in Europe and the U.S. Meanwhile, the proportion of ESRD patients that receive dialysis treatment is only 10%-20% in developing countries, much lower than 80% in Europe and the U.S.A.

As Chinese economy develops with increasing income per capita and payment ability of hemodialysis patients, the industry will develop rapidly in the future. The costs of hemodialysis consist of instruments, drugs and services...